An interventional study of Glucose containing Oral Rehydration Solution (ORS) and Sugar free - amino acid and electrolyte ORS in Gastroenteritis Acute, sponsored by Mead Johnson Nutrition. Completed at 4 sites in Thailand. Open to participants aged 1 Year to 5 Years. Per ClinicalTrials.gov, last updated 2024-03-25.
Sponsored by Mead Johnson Nutrition (part of Reckitt) · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a randomised, controlled, open-label study to determine the clinical effectiveness and safety of a novel ORS compared with a commercial ORS in children 1 to 5 years of age attending emergency departments with gastroenteritis.
237 studies on the registry are indexed under Gastroenteritis; 16 are open to participants now.
This study's enrollment of 60 is below the median of 136 across 164 interventional studies indexed under Gastroenteritis.
Browse Gastroenteritis studies →Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.
First submitted after Mead Johnson Nutrition became part of Reckitt.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dietary Supplement: Glucose containing Oral Rehydration Solution (ORS)
Dietary Supplement: Sugar free - amino acid and electrolyte ORS
Oral rehydration solution
Glucose free oral rehydration solution
Clinically assessed adequate rehydration based on clinical judgement of change in or absence of presenting symptoms from baseline (i.e. heart rate, urine output, etc.)
Assess change in clinical hydration status from presenting baseline status
Time frame: every 4 hours up to 24 hours or hospital discharge, whichever occurs first
Clinical Assessment of patient's hydration status based on presenting symptoms (i.e. heart rate, urine output, etc.)
5 point scale, 1(no discomfort) minimum, 5 (severe discomfort) maximum
Time frame: Baseline
Study ORS intake (units)
Time frame: Every 4 hours up to 24 hours or hospital discharge, whichever occurs first
Use of IV fluids
Time frame: up to 24 hours or hospital discharge, whichever occurs first
Weight
kg
Time frame: Every 4 hours up to 24 h or at hospital discharge, whichever occurs first
Participant comfort questionaire
Time frame: baseline and 24 hours or hospital discharge, whichever occurs first
Parent satisfaction questionnaire
Time frame: baseline and 24 hours or hospital discharge, whichever occurs first
Frequency of vomiting
Time frame: every 4 hours up to 24 hours or hospital discharge, whichever occurs first
Frequency episodes of urination
Time frame: every 4 hours up to 24 hours or hospital discharge, whichever occurs first
Frequency of liquid/watery stool
Time frame: every 4 hours up to 24 hours or hospital discharge, whichever occurs first
Time to resolution of liquid/water stool
Time frame: up to 24 hours or hospital discharge, whichever comes first
Stool for bacterial pathogen culture and viral antigens
Time frame: up to 24 hours or hospital discharge, whichever comes first
Time ready for discharge
Time frame: At discharge or 48 hours whichever occurs first
Medically confirmed adverse events collected throughout the study period
Time frame: 0 hours through 7 days post discharge
Record patient use of antibiotics during hospitalization
Time frame: up to 24 hours or hospital discharge, whichever comes first
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2022 to primary completion in Sep 2023, 14 months.
Of 17 interventional studies with no phase under Gastroenteritis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 22. This study's 14 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.